Efferocytosis Failure

The initiating event for autoimmune antibody production. Not a failure of immune activation — a failure of immune cleanup.

What Efferocytosis Is

Every day the body produces ~200–300 billion cells undergoing programmed death (apoptosis). Under normal conditions, macrophages and dendritic cells clear these dying cells within hours through efferocytosis — phagocytic engulfment before the cells lyse. When this clearance fails, apoptotic cells undergo secondary necrosis: they rupture, releasing their nuclear contents into the extracellular space.

Nuclear material (DNA, histones, ribonucleoproteins, citrullinated proteins) is recognized by TLR7 and TLR9 as viral-pattern danger signals. B cells and plasmacytoid dendritic cells respond by producing autoantibodies against this nuclear material. The adaptive immune system has been educated to attack self.

How Oxidized Lipids Impair It

MERTK and AXL receptor inactivation:

• These are the primary macrophage receptors for recognizing phosphatidylserine exposed on apoptotic cells
• OxLDL and OXLAMs bind to and downregulate MERTK expression through miR-155 upregulation
• Direct 4-HNE adduct formation impairs receptor function
• The more oxidized lipid burden a macrophage carries, the less efficiently it performs efferocytosis

C1q depletion:

• C1q is the complement protein that opsonizes apoptotic cells for macrophage recognition
• C1q is a collagen-domain protein requiring vitamin C, glycine, and lysine hydroxylation — same enzymes impaired in EDS
• The same enzyme impairment driving connective tissue fragility also reduces complement-mediated efferocytosis

Cholesterol efflux impairment:

• Macrophages must export cholesterol to perform repeated phagocytic cycles
• Oxidized cholesterol impairs ABCA1 and ABCG1 (cholesterol export transporters)
• Lipid-laden macrophages become foam cells: still present but non-functional for efferocytosis
• → Niacin restores ABCA1 expression; EPA/DHA → resolvins directly activate efferocytosis

The Gas6/Protein S — Vitamin K2 Connection

Gas6 and Protein S are the ligands for MERTK and AXL. Both are vitamin K2-dependent proteins (Gla proteins requiring carboxylation). Vitamin K2 deficiency → impaired Gas6/Protein S → impaired MERTK/AXL signaling → efferocytosis failure independent of the oxidized lipid receptor impairment.

MK-7 from natto is the most bioavailable dietary K2 source. This is why natto is non-optional in the protocol.

Condition-Specific Manifestations

Condition	Efferocytosis context	Consequence
[[Rheumatoid Arthritis]]	Synovial macrophages fail to clear NETotic debris	Anti-CCP antibody production
[[Endometriosis]]	Peritoneal macrophages fail to clear retrograde endometrial cells	Lesion establishment and persistence
[[Multiple Sclerosis]]	Microglia fail to clear myelin debris	Expanding antigen repertoire against myelin
[[EDS-MCAS-Eczema Cluster]]	Systemic low-grade efferocytosis impairment	Chronic mast cell priming

Resolution

• [[Phase 0 - Source Control and Redox]] — removes primary MERTK/AXL impairment signal
• [[Phase 1 - Gut Barrier]] — reduces LPS/OXLAM systemic burden
• EPA/DHA → resolvins D1/E1 → direct efferocytosis activation
• Vitamin K2 (MK-7 from natto) → Gas6/Protein S restoration
• Niacin → ABCA1 → macrophage cholesterol efflux capacity

Connections

• [[Oxidized Lipid Cascade]] — upstream mechanism
• [[Mast Cell Biology]] — parallel impairment pathway
• [[Estrobolome]] — the hormonal amplifier
• [[Rheumatoid Arthritis]] | [[Endometriosis]] | [[Multiple Sclerosis]] — tissue-specific consequences
• [[Collagen Synthesis Pathway]] — shared enzyme impairment (C1q/collagen connection)